サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1178026

人工血管市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Vascular Grafts Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 283 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
人工血管市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年11月16日
発行: Transparency Market Research
ページ情報: 英文 283 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の人工血管市場について調査し、市場の概要とともに、2022年～2031年の予測、製品別、人工血管サイズ別、原料別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー：世界の人工血管市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の人工血管市場の分析と予測、2017年～2031年

第5章 主な洞察

第6章 世界の人工血管市場の分析と予測、製品別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、製品別、2017年～2031年
    • 血管内ステントグラフト
    • 人工末梢血管
    • 血液透析アクセスグラフト
    • バイパスグラフト
    • その他
  • 製品別の市場魅力分析

第7章 世界の人工血管市場分析と予測、人工血管サイズ別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、人工血管サイズ別、2017年～2031年
    • 大型人工血管
    • 小型人工血管
  • 人工血管サイズ別の市場魅力分析

第8章 世界の人工血管市場の分析と予測、原料別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、原料別、2017年～2031年
    • 合成
    • 生物学的
    • 生合成
  • 原料別の市場魅力分析

第9章 世界の人工血管市場の分析と予測、用途別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、用途別、2017年～2031年
    • 冠動脈バイパス
    • 動脈瘤
    • 血管閉塞
    • 重症虚血肢
    • 腎不全
    • その他
  • 用途別の市場魅力分析

第10章 世界の人工血管市場の分析と予測、エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、エンドユーザー別、2017年～2031年
    • 病院
    • 外来手術センター
    • 心臓カテーテル研究所
    • 専門クリニック
    • その他
  • エンドユーザー別の市場魅力分析

第11章 世界の人工血管市場の分析と予測、地域別

  • 主な調査結果
  • 市場価値予測、地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場魅力分析

第12章 北米の人工血管市場の分析と予測

第13章 欧州の人工血管市場の分析と予測

第14章 アジア太平洋の人工血管市場の分析と予測

第15章 ラテンアメリカの人工血管市場の分析と予測

第16章 中東・アフリカの人工血管市場の分析と予測

第17章 競合情勢

  • 市場参入企業-競合マトリクス（層および企業規模別）
  • 市場シェア分析、企業別、2021年
  • 企業プロファイル
    • B. Braun SE
    • BD
    • Cook Medical, Inc.
    • CryoLife, Inc.
    • Getinge AB
    • Heart Medical
    • JUNKEN MEDICAL Co., Ltd.
    • LeMaitre Vascular, Inc.
    • Medtronic
    • Terumo Corporation
    • Vascular Graft Solutions
    • WL Gore &Associates, Inc.
図表

List of Tables

  • Table 01: Global Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 03: Global Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic Source, 2017-2031
  • Table 04: Global Vascular Graft Market Value (US$ Mn) Forecast, by Biological Source, 2017-2031
  • Table 05: Global Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2017-2031
  • Table 06: Global Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017-2031
  • Table 07: Global Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: Global Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Global Vascular Graft Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 10: North America Vascular Graft Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 11: North America Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 12: North America Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 13: North America Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017-2031
  • Table 14: North America Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017-2031
  • Table 15: North America Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017-2031
  • Table 16: North America Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017-2031
  • Table 17: North America Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 18: North America Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 21: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 22: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017-2031
  • Table 23: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017-2031
  • Table 24: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017-2031
  • Table 25: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017-2031
  • Table 26: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 27: Europe Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 28: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 29: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 30: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 31: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017-2031
  • Table 32: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017-2031
  • Table 33: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017-2031
  • Table 34: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017-2031
  • Table 35: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 36: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 37: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 38: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 39: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 40: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017-2031
  • Table 41: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017-2031
  • Table 42: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2017-2031

List of Figures

  • Figure 01: Global Vascular Grafts Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 02: Global Vascular Grafts Market Value Share, by Product, 2021
  • Figure 03: Global Vascular Grafts Market Value Share, by Size of Vascular Graft, 2021
  • Figure 04: Global Vascular Grafts Market Value Share, by Source, 2021
  • Figure 04: Global Vascular Grafts Market Value Share, by Application, 2021
  • Figure 04: Global Vascular Grafts Market Value Share, by End-user, 2021
  • Figure 05: Global Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 06: Global Vascular Grafts Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 09: Global Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
  • Figure 10: Global Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022-2031
  • Figure 11: Global Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
  • Figure 12: Global Vascular Grafts Market Attractiveness Analysis, by Source, 2022-2031
  • Figure 13: Global Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 14: Global Vascular Grafts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 15: Global Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 16: Global Vascular Grafts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 17: Global Vascular Grafts Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 18: Global Vascular Grafts Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 19: North America Vascular Grafts Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 20: North America Vascular Grafts Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 21: North America Vascular Grafts Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 22: North America Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 23: North America Vascular Grafts Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 24: North America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
  • Figure 25: North America Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022-2031
  • Figure 26: North America Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
  • Figure 27: North America Vascular Grafts Market Attractiveness Analysis, by Source, 2022-2031
  • Figure 28: North America Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 29: North America Vascular Grafts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 30: North America Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 31: North America Vascular Grafts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 32: Europe Vascular Grafts Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 33: Europe Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 34: Europe Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 35: Europe Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 36: Europe Vascular Grafts Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 37: Europe Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
  • Figure 38: Europe Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022-2031
  • Figure 39: Europe Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
  • Figure 40: Europe Vascular Grafts Market Attractiveness Analysis, by Source, 2022-2031
  • Figure 41: Europe Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 42: Europe Vascular Grafts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 43: Europe Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 44: Europe Vascular Grafts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 45: Asia Pacific Vascular Grafts Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 46: Asia Pacific Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 47: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 48: Asia Pacific Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 49: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 50: Asia Pacific Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
  • Figure 51: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022-2031
  • Figure 52: Asia Pacific Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
  • Figure 53: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Source, 2022-2031
  • Figure 54: Asia Pacific Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 55: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 56: Asia Pacific Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 57: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 58: Latin America Vascular Grafts Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 59: Latin America Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 60: Latin America Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 61: Latin America Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 62: Latin America Vascular Grafts Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 63: Latin America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
  • Figure 64: Latin America Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022-2031
  • Figure 65: Latin America Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
  • Figure 66: Latin America Vascular Grafts Market Attractiveness Analysis, by Source, 2022-2031
  • Figure 67: Latin America Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 68: Latin America Vascular Grafts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 69: Latin America Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 70: Latin America Vascular Grafts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 71: Middle East & Africa Vascular Grafts Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 72: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 73: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 74: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 75: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 76: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031
  • Figure 77: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022-2031
  • Figure 78: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031
  • Figure 79: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Source, 2022-2031
  • Figure 80: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 81: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 82: Middle East & Africa Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 83: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 84: Company Share Analysis, 2021
目次
Product Code: TMRGL11096

TMR's report on the global vascular grafts market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global vascular grafts market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vascular grafts market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the vascular grafts market.

The report delves into the competitive landscape of the global vascular grafts market. Key players operating in the global vascular grafts market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global vascular grafts market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Vascular Grafts Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Vascular Grafts Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Global Prevalence of Chronic Kidney Diseases
  • 5.3. Global Prevalence of Cardiovascular Diseases
  • 5.4. Covid-19 Pandemic Impact on the Industry

6. Global Vascular Grafts Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Endovascular Stent Graft
    • 6.3.2. Peripheral Vascular Graft
    • 6.3.3. Hemodialysis Access Graft
    • 6.3.4. Bypass Graft
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Vascular Grafts Market Analysis and Forecast, by Size of Vascular Graft

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
    • 7.3.1. Large Size Vascular Graft
    • 7.3.2. Small Size Vascular Graft
  • 7.4. Market Attractiveness Analysis, by Size of Vascular Graft

8. Global Vascular Grafts Market Analysis and Forecast, by Source

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Source, 2017-2031
    • 8.3.1. Synthetic
      • 8.3.1.1. Polytetrafluethylene (PTFE)
      • 8.3.1.2. Polyurethane (PU)
      • 8.3.1.3. Dacron
      • 8.3.1.4. Others
    • 8.3.2. Biological
      • 8.3.2.1. Bovine Vein
      • 8.3.2.2. Saphenous Vein
      • 8.3.2.3. Others
    • 8.3.3. Biosynthetic
      • 8.3.3.1. Ovine Collagen with Polyester
      • 8.3.3.2. Others
  • 8.4. Market Attractiveness Analysis, by Source

9. Global Vascular Grafts Market Analysis and Forecast, by Application

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Application, 2017-2031
    • 9.3.1. Coronary Artery Bypass
    • 9.3.2. Aneurysm
    • 9.3.3. Vascular Occlusion
    • 9.3.4. Critical Limb Ischemia
    • 9.3.5. Renal Failure
    • 9.3.6. Others
  • 9.4. Market Attractiveness Analysis, by Application

10. Global Vascular Grafts Market Analysis and Forecast, by End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Ambulatory Surgery Centers
    • 10.3.3. Cardiac Catheterization Laboratories
    • 10.3.4. Specialty Clinics
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis, by End-user

11. Global Vascular Grafts Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Vascular Grafts Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Endovascular Stent Graft
    • 12.2.2. Peripheral Vascular Graft
    • 12.2.3. Hemodialysis Access Graft
    • 12.2.4. Bypass Graft
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
    • 12.3.1. Large Size Vascular Graft
    • 12.3.2. Small Size Vascular Graft
  • 12.4. Market Value Forecast, by Source, 2017-2031
    • 12.4.1. Synthetic
      • 12.4.1.1. Polytetrafluethylene (PTFE)
      • 12.4.1.2. Polyurethane (PU)
      • 12.4.1.3. Dacron
      • 12.4.1.4. Others
    • 12.4.2. Biological
      • 12.4.2.1. Bovine Vein
      • 12.4.2.2. Saphenous Vein
      • 12.4.2.3. Others
    • 12.4.3. Biosynthetic
      • 12.4.3.1. Ovine Collagen with Polyester
      • 12.4.3.2. Others
  • 12.5. Market Value Forecast, by Application , 2017-2031
    • 12.5.1. Coronary Artery Bypass
    • 12.5.2. Aneurysm
    • 12.5.3. Vascular Occlusion
    • 12.5.4. Critical Limb Ischemia
    • 12.5.5. Renal Failure
    • 12.5.6. Others
  • 12.6. Market Value Forecast, by End-user, 2017-2031
    • 12.6.1. Hospitals
    • 12.6.2. Ambulatory Surgery Centers
    • 12.6.3. Cardiac Catheterization Laboratories
    • 12.6.4. Specialty Clinics
    • 12.6.5. Others
  • 12.7. Market Value Forecast, by Country, 2017-2031
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Product
    • 12.8.2. By Size of Vascular Graft
    • 12.8.3. By Source
    • 12.8.4. By Application
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Vascular Grafts Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Endovascular Stent Graft
    • 13.2.2. Peripheral Vascular Graft
    • 13.2.3. Hemodialysis Access Graft
    • 13.2.4. Bypass Graft
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
    • 13.3.1. Large Size Vascular Graft
    • 13.3.2. Small Size Vascular Graft
  • 13.4. Market Value Forecast, by Source, 2017-2031
    • 13.4.1. Synthetic
      • 13.4.1.1. Polytetrafluethylene (PTFE)
      • 13.4.1.2. Polyurethane (PU)
      • 13.4.1.3. Dacron
      • 13.4.1.4. Others
    • 13.4.2. Biological
      • 13.4.2.1. Bovine Vein
      • 13.4.2.2. Saphenous Vein
      • 13.4.2.3. Others
    • 13.4.3. Biosynthetic
      • 13.4.3.1. Ovine Collagen with Polyester
      • 13.4.3.2. Others
  • 13.5. Market Value Forecast, by Application, 2017-2031
    • 13.5.1. Coronary Artery Bypass
    • 13.5.2. Aneurysm
    • 13.5.3. Vascular Occlusion
    • 13.5.4. Critical Limb Ischemia
    • 13.5.5. Renal Failure
    • 13.5.6. Others
  • 13.6. Market Value Forecast, by End-user, 2017-2031
    • 13.6.1. Hospitals
    • 13.6.2. Ambulatory Surgery Centers
    • 13.6.3. Cardiac Catheterization Laboratories
    • 13.6.4. Specialty Clinics
    • 13.6.5. Others
  • 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Product
    • 13.8.2. By Size of Vascular Graft
    • 13.8.3. By Source
    • 13.8.4. By Application
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Vascular Grafts Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Endovascular Stent Graft
    • 14.2.2. Peripheral Vascular Graft
    • 14.2.3. Hemodialysis Access Graft
    • 14.2.4. Bypass Graft
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
    • 14.3.1. Large Size Vascular Graft
    • 14.3.2. Small Size Vascular Graft
  • 14.4. Market Value Forecast, by Source, 2017-2031
    • 14.4.1. Synthetic
      • 14.4.1.1. Polytetrafluethylene (PTFE)
      • 14.4.1.2. Polyurethane (PU)
      • 14.4.1.3. Dacron
      • 14.4.1.4. Others
    • 14.4.2. Biological
      • 14.4.2.1. Bovine Vein
      • 14.4.2.2. Saphenous Vein
      • 14.4.2.3. Others
    • 14.4.3. Biosynthetic
      • 14.4.3.1. Ovine Collagen with Polyester
      • 14.4.3.2. Others
  • 14.5. Market Value Forecast, by Application, 2017-2031
    • 14.5.1. Coronary Artery Bypass
    • 14.5.2. Aneurysm
    • 14.5.3. Vascular Occlusion
    • 14.5.4. Critical Limb Ischemia
    • 14.5.5. Renal Failure
    • 14.5.6. Others
  • 14.6. Market Value Forecast, by End-user, 2017-2031
    • 14.6.1. Hospitals
    • 14.6.2. Ambulatory Surgery Centers
    • 14.6.3. Cardiac Catheterization Laboratories
    • 14.6.4. Specialty Clinics
    • 14.6.5. Others
  • 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Product
    • 14.8.2. By Size of Vascular Graft
    • 14.8.3. By Source
    • 14.8.4. By Application
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Vascular Grafts Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Endovascular Stent Graft
    • 15.2.2. Peripheral Vascular Graft
    • 15.2.3. Hemodialysis Access Graft
    • 15.2.4. Bypass Graft
    • 15.2.5. Others
  • 15.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
    • 15.3.1. Large Size Vascular Graft
    • 15.3.2. Small Size Vascular Graft
  • 15.4. Market Value Forecast, by Source, 2017-2031
    • 15.4.1. Synthetic
      • 15.4.1.1. Polytetrafluethylene (PTFE)
      • 15.4.1.2. Polyurethane (PU)
      • 15.4.1.3. Dacron
      • 15.4.1.4. Others
    • 15.4.2. Biological
      • 15.4.2.1. Bovine Vein
      • 15.4.2.2. Saphenous Vein
      • 15.4.2.3. Others
    • 15.4.3. Biosynthetic
      • 15.4.3.1. Ovine Collagen with Polyester
      • 15.4.3.2. Others
  • 15.5. Market Value Forecast, by Application , 2017-2031
    • 15.5.1. Coronary Artery Bypass
    • 15.5.2. Aneurysm
    • 15.5.3. Vascular Occlusion
    • 15.5.4. Critical Limb Ischemia
    • 15.5.5. Renal Failure
    • 15.5.6. Others
  • 15.6. Market Value Forecast, by End-user, 2017-2031
    • 15.6.1. Hospitals
    • 15.6.2. Ambulatory Surgery Centers
    • 15.6.3. Cardiac Catheterization Laboratories
    • 15.6.4. Specialty Clinics
    • 15.6.5. Others
  • 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Product
    • 15.8.2. By Size of Vascular Graft
    • 15.8.3. By Source
    • 15.8.4. By Application
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Vascular Grafts Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Product, 2017-2031
    • 16.2.1. Endovascular Stent Graft
    • 16.2.2. Peripheral Vascular Graft
    • 16.2.3. Hemodialysis Access Graft
    • 16.2.4. Bypass Graft
    • 16.2.5. Others
  • 16.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
    • 16.3.1. Large Size Vascular Graft
    • 16.3.2. Small Size Vascular Graft
  • 16.4. Market Value Forecast, by Source, 2017-2031
    • 16.4.1. Synthetic
      • 16.4.1.1. Polytetrafluethylene (PTFE)
      • 16.4.1.2. Polyurethane (PU)
      • 16.4.1.3. Dacron
      • 16.4.1.4. Others
    • 16.4.2. Biological
      • 16.4.2.1. Bovine Vein
      • 16.4.2.2. Saphenous Vein
      • 16.4.2.3. Others
    • 16.4.3. Biosynthetic
      • 16.4.3.1. Ovine Collagen with Polyester
      • 16.4.3.2. Others
  • 16.5. Market Value Forecast, by Application, 2017-2031
    • 16.5.1. Coronary Artery Bypass
    • 16.5.2. Aneurysm
    • 16.5.3. Vascular Occlusion
    • 16.5.4. Critical Limb Ischemia
    • 16.5.5. Renal Failure
    • 16.5.6. Others
  • 16.6. Market Value Forecast, by End-user, 2017-2031
    • 16.6.1. Hospitals
    • 16.6.2. Ambulatory Surgery Centers
    • 16.6.3. Cardiac Catheterization Laboratories
    • 16.6.4. Specialty Clinics
    • 16.6.5. Others
  • 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Product
    • 16.8.2. By Size of Vascular Graft
    • 16.8.3. By Source
    • 16.8.4. By Application
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (by tier and size of companies)
  • 17.2. Market Share Analysis, by Company, 2021
  • 17.3. Company Profiles
    • 17.3.1. B. Braun SE
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. SWOT Analysis
      • 17.3.1.4. Strategic Overview
    • 17.3.2. BD
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. SWOT Analysis
      • 17.3.2.4. Strategic Overview
    • 17.3.3. Cook Medical, Inc.
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. SWOT Analysis
      • 17.3.3.4. Strategic Overview
    • 17.3.4. CryoLife, Inc.
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. SWOT Analysis
      • 17.3.4.4. Strategic Overview
    • 17.3.5. Getinge AB
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. SWOT Analysis
      • 17.3.5.4. Strategic Overview
    • 17.3.6. Heart Medical
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. SWOT Analysis
      • 17.3.6.4. Strategic Overview
    • 17.3.7. JUNKEN MEDICAL Co., Ltd.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. SWOT Analysis
      • 17.3.7.4. Strategic Overview
    • 17.3.8. LeMaitre Vascular, Inc.
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. SWOT Analysis
      • 17.3.8.4. Strategic Overview
    • 17.3.9. Medtronic
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. SWOT Analysis
      • 17.3.9.4. Strategic Overview
    • 17.3.10. Terumo Corporation
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. SWOT Analysis
      • 17.3.10.4. Strategic Overview
    • 17.3.11. Vascular Graft Solutions
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Product Portfolio
      • 17.3.11.3. SWOT Analysis
      • 17.3.11.4. Strategic Overview
    • 17.3.12. W. L. Gore & Associates, Inc.
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Product Portfolio
      • 17.3.12.3. SWOT Analysis
      • 17.3.12.4. Strategic Overview